Posts

Pancreatic Lipomatosis in Cystic Fibrosis: CT, MRI, and Ultrasound Findings

Image
Understanding Fatty Replacement of the Pancreas, Exocrine Pancreatic Insufficiency, and Its Clinical Significance Executive Answer Pancreatic lipomatosis is a characteristic abdominal imaging manifestation of cystic fibrosis (CF), resulting from progressive pancreatic duct obstruction, acinar injury, fibrosis, and replacement of functional pancreatic tissue by fat. On CT, the affected pancreas demonstrates diffuse or extensive low attenuation, sometimes with substantial enlargement despite loss of normal glandular tissue. Ultrasound typically shows increased pancreatic echogenicity, while T1-weighted MRI demonstrates increased signal intensity from fatty replacement. Recognizing these findings is clinically important because pancreatic structural abnormalities frequently coexist with exocrine pancreatic insufficiency, malabsorption, nutritional impairment, and cystic fibrosis-related diabetes. 1. Introduction: Why Pancreatic Lipomatosis Matters in Cystic Fibrosis Cystic fibrosis is an ...

Aortic Intramural Hematoma: CT Diagnosis, High-Risk Imaging Features, and the Clinical Dilemma of TEVAR

Image
When a Type B Aortic Intramural Hematoma Evolves Into Retrograde Type A Dissection By Dr. Elias Lee | ScholarGen MediAI Executive Answer Aortic intramural hematoma (IMH) is an acute aortic syndrome characterized by hemorrhage within the aortic media, typically appearing on noncontrast CT as crescentic or circumferential hyperattenuating aortic wall thickening without a patent false lumen. Recognizing IMH requires careful assessment of aortic wall thickness, total aortic diameter, focal intimal disruption, ulcer-like projections, and interval progression. Although uncomplicated Stanford type B IMH may be managed initially with anti-inflammatory medical therapy and close imaging surveillance, high-risk imaging findings can justify intervention. Importantly, thoracic endovascular aortic repair (TEVAR) introduces its own risks, including retrograde type A aortic dissection. 1. Why This Case Matters Acute aortic syndromes are among the most consequential diagnoses encountered in emergency r...

Combined Pulmonary Fibrosis and Emphysema (CPFE): HRCT Findings, Preserved Spirometry, Reduced DLCO, and the Critical Role of Pulmonary Hypertension

Image
 Edited by ScholarGen MediAI Team A Radiologic and Clinical Approach to Recognizing Combined Pulmonary Fibrosis and Emphysema Executive Answer Combined pulmonary fibrosis and emphysema (CPFE) is a clinically important syndrome characterized by the coexistence of pulmonary emphysema and fibrotic interstitial lung disease. Its characteristic imaging pattern often includes upper-lung-predominant emphysema and lower-lung-predominant fibrosis, although distribution varies. One of its most important clinical features is the apparent mismatch between relatively preserved spirometry and substantially impaired gas transfer, reflected by a reduced diffusing capacity for carbon monoxide (DLCO). Recognizing this combination on high-resolution CT (HRCT) is essential because pulmonary hypertension, lung cancer, progressive respiratory impairment, and increased mortality are important complications. 1. Why Combined Pulmonary Fibrosis and Emphysema Deserves Special Attention In thoracic radiology,...